Laxmi Dental Limited has formally incorporated Leelaben Foundation, a Section 8 company dedicated to managing the firm's Corporate Social Responsibility initiatives. The new entity received its Certificate of Incorporation from the Ministry of Corporate Affairs on October 21, 2026.

The foundation is structured as a company limited by guarantee under the Companies Act, 2013. Its registered office is located in Mumbai, Maharashtra, aligning with the parent company's operational base. This step follows the Board of Directors' approval granted during a meeting held on October 8, 2026.

Regulatory Compliance and Disclosure

The incorporation was disclosed to the stock exchanges under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company confirmed that the licence under Section 8(1) of the Companies Act, 2013 was issued simultaneously with the certificate of incorporation. The relevant documents are available for public viewing on the company's official website.

Foundation Details

The newly formed entity operates as a non-profit organization focused on social welfare projects funded by Laxmi Dental. Key registration details are outlined below:

This structural move allows the company to channel its CSR spending through a dedicated legal entity, ensuring compliance with statutory requirements while maintaining transparency in fund utilization.

Laxmi Dental Limited subsidiary Laxmi Dental Lab USA Inc received a tariff refund of $0.63 million (approximately ₹59.20 crore) from the US Customs and Border Protection (CBP).

The refund follows US Supreme Court directives instructing the government to return excess tariffs collected from importers. The company disclosed this development in a filing dated October 21, 2026, under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Regulatory disclosure details

The company informed BSE Limited and National Stock Exchange of India Limited about the receipt of funds. The disclosure highlights that the refund is a direct consequence of judicial intervention regarding tariff collections. The information was also made available on the company’s website for public access.

Financial impact summary

The table below summarizes the key financial figures associated with this event:

What the numbers show

The receipt of $0.63 million represents a direct cash inflow for the US subsidiary, Laxmi Dental Lab USA Inc. While the source does not provide the total revenue or profit figures for the period, the refund amount of ₹59.20 crore is a material one-time gain relative to typical operational cash flows for mid-cap dental manufacturers. This inflow improves the subsidiary’s liquidity position without requiring operational performance changes.